| Date | Form | Description | Docs | XBRL | Pages |
| 03/09/18 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
31 |
| 09/08/17 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
35 |
| 05/26/17 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
32 |
| 03/16/17 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
31 |
| 08/19/16 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
35 |
| 05/20/16 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
34 |
| 02/19/16 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
30 |
| 08/18/15 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
37 |
| 05/22/15 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
44 |
| 03/09/15 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
39 |
Latest News & Events
Anixa Biosciences Announces Support from the National Cancer Institute for Ovarian Cancer Vaccine Developed by Cleveland Clinic
Read More...Anixa Biosciences and Moffitt Cancer Center Receive Additional Information Request from US FDA for CAR-T IND Application
Read More...OntoChem Assigns Anixa Covid-19 Drug Discovery Project to MolGenie
Read More...